Equilibra Bioscience
FL - NaplesBiotechnology
Focus: Equilibra Bioscience is a pre-clinical stage biotechnology company focused on developing an anti-activated Protein C monoclonal antibody therapeutic. The company operates from Naples, Florida with minimal public disclosure of scale or market position.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Equilibra Bioscience
AI assessmentNot HiringNo open roles listed right now. Follow Equilibra Bioscience to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SR604
Healthy ParticipantsClinical Trials (1)
NCT06349473A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Phase 1Help build intelligence for Equilibra Bioscience
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.